期刊文献+

医疗机构药品不良反应监测的优化实践 被引量:25

Optimization Practice of The Medical Institutions Adverse Drug Reaction Monitoring Method
在线阅读 下载PDF
导出
摘要 目的形成适合大型医疗机构的系统性药品不良反应(ADR)监测工作模式。方法利用良好的医院信息系统(HIS)运行环境和临床药学工作基础展开实践。结果形成了ADR监测的3级工作团队、2项工作规章、6项操作规程、1套药品安全突发事件应急处置流程、1本刊物、1份通报,实现了ADR数据采集、评价、分析、信息预警和流转的电子化,完成了多项结合实际的药品安全性评价应用研究。结论通过规章流程建设、信息平台开发、数据利用、应急处置和宣教培训的多方位工作探索与实践,优化了医疗机构药品ADR监测模式,成为药品风险控制的坚实前哨。 Objective To form systemic adverse drug reaction monitoring mode of the large-scale medical institution. Methods Practice on the basis of good hospital information system(HIS) operation environment and clinical pharmacy developement. Results The formation of grade 3 monitoring work team, 2 work rules, 6 procedures, a set of drug safety and emergency treatment process, a house journal, a bulletin, obtains ADR data acquisition, evaluation, analysis, early warning and transmission of electronic information, and combining with actual completed a series of drug safety evaluation of applied research. Conclusion Through the rules and process electronic platform construction, development, data utilization, emergency disposal and intersectorial work missionary training to optimize the exploration and practice of medical institution, obtains the solid outpost of drug safety and risk management.
出处 《中国药物警戒》 2010年第3期164-168,共5页 Chinese Journal of Pharmacovigilance
关键词 药品不良反应(ADR)监测 电子报告 数据利用 工作流程 药品安全 adverse drug reaction(ADR.) monitoring , electronic report data utilization work process drug safety
  • 相关文献

参考文献3

二级参考文献13

  • 1刘莹,王玉,曾昭全.530例药物不良反应报告分析[J].药物不良反应杂志,2005,7(1):61-63. 被引量:29
  • 2曾兆纲,孙克红,阿力木江,王新彬,邵惠,姜红.88例药物不良反应报告分析[J].药物不良反应杂志,2005,7(2):143-144. 被引量:6
  • 3纪立伟,李可欣,傅得兴.222份药品不良反应报告表质量评价[J].药物不良反应杂志,2005,7(6):458-460. 被引量:11
  • 4[1]国家药品不良反应监测中心暨国家食品药品监督管理局药品评价中心.WHO药品不良反应术语集[M].北京:中国医药科技出版社,2003.
  • 5Park-Wyllie LY,Juurlink DN and Kopp A,et al.Outpatient gatifloxacin therapy and dysglycemia in older adults[J].N Engl J Med,2006,354(13):1413-1415.
  • 6Kendall C,Wooltorton E.People with diabetes should avoid antibiotic gatifloxacin[J].CMA J,2006,174 (8):1089-1090.
  • 7Beste LA,Mersfelder TL.Hyperglycemia and gatitloxacin:a case report and summary of current literature[J].Am J Geriatr Pharmacother,2005,3 (4):262-265.
  • 8Arce FC,Bhasin RS,Pasmantier R.Severe hyperglycemia during gatifloxacin therapy in patients without diabetes[J].Endocr Pract,2004,10(1):40-44.
  • 9Ishiwaha Y,Sanada Y,Yasuhara M.Effects of gatifloxacin on glucose concentration in normal and diabetic rats[J].Biol Pharm Bull,2006,29 (3):527-531.
  • 10Updated safety information for TEQUIN * (gatifloxacin) and serious hypoglycemia and hyperglycemia.[EB/OL].http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/ 2006 / tequin_2_hpc-cps_e.html,2006-5-12.

共引文献51

同被引文献195

引证文献25

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部